003060.KS Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (23 Apr 2024 @ 02:05):

Aprogen pharmaceuticals,Inc. manufactures and sells pharmaceutical products primarily in South Korea. It offers approximately 200 types of medicines, including ethical and over the counter drugs...

Stats
Today's Volume	4.67M
Average Volume	761 727
Market Cap	112.64B
EPS	KRW0 ( 2024-03-15 )
Next earnings date	( KRW0 ) 2024-05-10
Last Dividend	KRW0 ( N/A )
Next Dividend	KRW0 ( N/A )
P/E	0
ATR14	KRW24.03 (1.38%)

Volume Correlation

Long: -0.06 (neutral)

Short: 0.57 (weak)

Signal:(38.178) Neutral

Aprogen Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Aprogen Correlation - Currency/Commodity

-0.41
( neutral )

-0.34
( neutral )

-0.22
( neutral )

-0.44
( neutral )

0.46
( neutral )

0.11
( neutral )

Aprogen Financials

Annual	2023
Revenue:	KRW87.36B
Gross Profit:	KRW-12.05B (-13.79 %)
EPS:	KRW-187.48

Q4	2023
Revenue:	KRW22.70B
Gross Profit:	KRW-4.54B (-19.99 %)
EPS:	KRW-147.22

Q3	2023
Revenue:	KRW20.13B
Gross Profit:	KRW-3.16B (-15.67 %)
EPS:	KRW-7.39

Q2	2023
Revenue:	KRW27.07B
Gross Profit:	KRW-449.71M (-1.66 %)
EPS:	KRW-28.14

Financial Reports:

No articles found.

Aprogen

Aprogen pharmaceuticals,Inc. manufactures and sells pharmaceutical products primarily in South Korea. It offers approximately 200 types of medicines, including ethical and over the counter drugs. The company offers its drugs for transfusion, digestive system, osteoarthritis, skeletal muscle relaxants, NSAIDs, osteoporosis, circulatory system, endocrine, respiratory system, urinary system, depilatory, antihistamines and antiallergics, obesity, brain function, neurologics, and male pattern hair loss. It also provides anti-biotic, anti-fungal, anti-viral, anti-ulcerant, anti-epliepsy products; external agents; anti-cancer drugs; amino-acid nutrient transfusion agents; and cosmetics. The company was formerly known as Schnell Biopharmaceuticals, Inc. and changed its name to Aprogen pharmaceuticals,Inc. in April 2017. Aprogen pharmaceuticals,Inc. was founded in 1960 and is headquartered in Seongnam, South Korea.